Evidence map›Paper›PMID 16223512›Full record

ArticleLife sciences2006

Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.

Atsushi Miyamoto, Ryoko Wada, Aya Inoue, Shigeru Ishiguro, James K Liao, Akira Nishio

Open access · greenAbstract read
In one paragraph

Article in Life sciences, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Atsushi MiyamotoDepartment of Veterinary Pharmacology, Faculty of Agriculture, Kagoshima University, Kagoshima, 1-21-24 Korimoto, Kagoshima 890-0065, Japan.
Ryoko Wada
Aya Inoue
Shigeru Ishiguro
James K Liao
Akira Nishio
Kagoshima University · JPBrigham and Women's Hospital · US

Funding

TRIGEMINOVASCULAR CONTROL OF CEREBRAL BLOOD VESSELSP50NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LIAO, JAMES KUANG-JAN · 1985 to 2007
$10.8M
LIPOPROTEINS EFFECTS ON G PROTEIN FUNCTIONR01HL052233 · NHLBI · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 1995 to 2016
$5.3M
Activation of eNOS by Steroid HormonesR01HL070274 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, JAMES KUANG-JAN · 2002 to 2006
$2.2M
Role of PI3-Kinase in Estrogen-induced eNOS ActivationR01DK062729 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, JAMES KUANG-JAN · 2003 to 2007
$1.9M
Role of protein kinase Akt in cerebral ischemiaP01NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1989 to 2008
$1.4M
NHLBI NIH HHS R01 HL052233NHLBI NIH HHS R01 HL070274NIDDK NIH HHS R01 DK062729NINDS NIH HHS P01 NS010828NINDS NIH HHS P50 NS010828
6 · The paper itself

Abstract

We aimed to clarify responsiveness to angiotensin (Ang) II in the porcine basilar artery and the role of Ang II receptor subtypes by functional, radioligand binding, and cell culture studies. Ang II induced more potent contractions in the proximal part than in the distal part of isolated porcine basilar arteries. The contraction induced by Ang II was inhibited by the Ang II type 1 (AT1) receptor antagonist losartan, but the Ang II type 2 (AT2) receptor antagonist PD123319 enhanced it. After removal of the endothelium, the effect of losartan remained but the effect of PD123319 was abolished. The specific binding site of [3H]Ang II on the smooth muscle membrane was inhibited by losartan, but not by PD123319. Stimulation of angiotensin II increased nitric oxide (NO) production in cultured basilar arterial endothelial cells. This production was inhibited by PD123319 and the NO synthase inhibitor L-NG-nitroarginine. These results suggest that the contraction induced by Ang II might be mediated via the activation of AT1 receptors on the basilar arterial smooth muscle cells and be modulated via the activation of AT2 receptors on the endothelial cells, followed by NO production.

Indexed as

Angiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersAngiotensin Receptor AntagonistsAnimalsBasilar ArteryCells, CulturedEndothelial CellsEnzyme InhibitorsFemaleImidazolesIndicators and ReagentsIn Vitro TechniquesLosartanMaleMuscle ContractionMuscle, Smooth, VascularAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersAngiotensin Receptor AntagonistsEnzyme InhibitorsImidazolesIndicators and ReagentsLosartanNitric Oxide Synthase Type IIINitroargininePD 123319PyridinesReceptor, Angiotensin, Type 2Receptors, Angiotensin

Identifiers

PMID16223512
PMCPMC2641039
OpenAlexW2045933418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.